NCT05257785 (Lymfit_RCT) is a NA clinical trial of Lymfit exercise intervention in Lymphoma, sponsored by McGill University.

Who is sponsoring NCT05257785?

NCT05257785 is sponsored by McGill University.

What drugs are being tested in NCT05257785?

Interventions in NCT05257785: Lymfit exercise intervention, Waitlist control.

What condition does NCT05257785 study?

NCT05257785 studies Lymphoma, Cancer Survivors.

Is NCT05257785 still recruiting?

NCT05257785 is currently recruiting now. Last updated 5 April 2024.

Last reviewed 2024-04-05 · How we verify

NCT05257785: Lymfit_RCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors

Recruiting now NA Last updated 5 April 2024

What this trial tests

NA trial testing Lymfit exercise intervention in Lymphoma in 50 participants. Currently enrolling.

Timeline

15 January 2022

Primary endpoint
1 December 2024

1 December 2024

Quick facts

Lead sponsor	McGill University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	50
Start date	15 January 2022
Primary completion	1 December 2024
Estimated completion	1 December 2024
Sites	1 location across Canada

Drugs / interventions tested

Lymfit exercise intervention
Waitlist control

Conditions studied

Lymphoma — all drugs for Lymphoma →
Cancer Survivors — all drugs for Cancer Survivors →

Sponsor

McGill University

Who can join

Adults 18 to 39, any sex, with Lymphoma or Cancer Survivors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized control trial seeks to determine whether a tailored and supervised exercise program adopting mobile-health technology will be able to improve fitness and quality of life among lymphoma survivors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cardiovascular training for fatigue in people with cancer.
Wagner C, Ernst M, Cryns N, Oeser A, et al · · 2025 · cited 1× · PMID 39976199 · DOI 10.1002/14651858.cd015517

Verify or expand the search:

Other recruiting trials for Lymphoma

Currently open trials in the same condition.

NCT07302347 — A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participan · Phase 1, PHASE2 · recruiting
NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
NCT06856226 — Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing · recruiting
NCT07226934 — An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers · NA · recruiting
NCT07138547 — GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma · Phase 1, PHASE2 · recruiting

Other McGill University trials

Trials by the same sponsor.

NCT07178535 — Feasibility of Real-Time Visual Feedback in Augmented Reality to Reduce Gait Asymmetry Post-Stroke · NA · not yet recruiting
NCT07445841 — Protecting the Brain From Post-Stroke Cognitive Impairment and Dementia With Multimodal Exercise Training · NA · recruiting
NCT07447830 — The Pain Reduction Using Immersive Virtual Reality During Wound Care Evaluation Study at Maimonides (PRISM) - Pilot Stud · NA · recruiting
NCT07497425 — Neuroimmune Responses to Exercise in Chronic Back Pain · NA · recruiting
NCT06994559 — Music as an Adjunct to Ketamine Therapy for Chronic Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05257785 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by McGill University
Last refreshed: 5 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05257785.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing